ArticleBMC pharmacology & toxicology2019

Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways.

Andrea Huppertz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.